World's Best Scientists 2026 revealed!
Richard Rosenquist

Richard Rosenquist

Award Badge
Biology and Biochemistry
Sweden
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
84
Citations
22598
World Ranking
3367
National Ranking
52

Medicine

D-Index
90
Citations
28458
World Ranking
12244
National Ranking
232

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Sweden Leader Award

Overview

Richard Rosenquist is affiliated with the Karolinska Institute in Sweden. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a substantial focus on Genetics, Pathology and Forensic Medicine, Cancer Research, Immunology, and Molecular Biology.

The scientist's main topics of research encompass Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Cancer Genomics and Diagnostics, Immunodeficiency and Autoimmune Disorders, Genomics and Rare Diseases, Acute Myeloid Leukemia Research, and Genetic factors in colorectal cancer.

Frequent publication venues for Richard Rosenquist include Blood, Leukemia, Frontiers in Oncology, HemaSphere, and Seminars in Cancer Biology. The number of publications in these venues reflects an ongoing engagement with journals that focus on hematology, oncology, and cancer biology.

  • Blood (18 publications)
  • Leukemia (12 publications)
  • Frontiers in Oncology (9 publications)
  • HemaSphere (6 publications)
  • Seminars in Cancer Biology (5 publications)

Recent notable papers authored or co-authored by Richard Rosenquist include:

  • "Genomic profiling for clinical decision making in lymphoid neoplasms," 2022, Blood
  • "International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia," 2020, Blood
  • "Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL," 2020, Blood
  • "Clinical utility of whole-genome sequencing in precision oncology," 2021, Seminars in Cancer Biology
  • "Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL," 2022, Leukemia

Collaborations are an integral part of the scientist's work, with frequent co-authors including Κώστας Σταματόπουλος, Paolo Ghia, Larry Mansouri, Šárka Pospı́šilová, and Lydia Scarfò. The number of collaborative publications indicates sustained research partnerships across studies related to hematologic malignancies and cancer genomics.

Best Publications

  • Regional anesthesia in the anticoagulated patient: Defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation)

    Terese T. Horlocker;Denise J. Wedel;Honorio T Benzon;David L. Brown

  • Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

    Eva Baecklund;Anastasia Iliadou;Johan Askling;Anders Ekbom;Anders Ekbom

  • Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society.

    Roger Chou;John D. Loeser;Douglas K. Owens;Douglas K. Owens;Richard W. Rosenquist

  • Nonsurgical interventional therapies for low back pain: a review of the evidence for an American Pain Society clinical practice guideline.

    Roger Chou;Steven J. Atlas;Steven P. Stanos;Richard W. Rosenquist

  • Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

    Andreas Agathangelidis;Nikos Darzentas;Anastasia Hadzidimitriou;Xavier Brochet

  • SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.

    Luca Malcovati;Mohsen Karimi;Elli Papaemmanuil;Ilaria Ambaglio

  • Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia.

    Aparna Raval;Stephan M. Tanner;John C. Byrd;Elizabeth B. Angerman

  • Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia

    Gerard Tobin;Ulf Thunberg;Anna Johnson;Ingrid Thörn

  • Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis

    Fiona Murray;Nikos Darzentas;Anastasia Hadzidimitriou;Gerard Tobin

  • Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

    Fergus J. Couch;Xianshu Wang;Lesley McGuffog;Andrew Lee

  • Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vλ2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope

    Gerard Tobin;Ulf Thunberg;Anna Johnson;Inger Eriksson

  • Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

    P Baliakas;A Hadzidimitriou;L-A Sutton;D Rossi

  • Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia.

    Gerard Tobin;Ulf Thunberg;Karin Karlsson;Fiona Murray

  • A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies

    Anna Lanemo Myhrinder;Eva Hellqvist;Ekaterina Sidorova;Anita Söderberg

  • ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia.

    Paolo Ghia;K. Stamatopoulos;C. Belessi;C. Moreno

  • Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

    Mattias Berglund;Ulf Thunberg;Rose-Marie Amini;Majlis Book

  • Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

    Ekaterina Chigrinova;Andrea Rinaldi;Ivo Kwee;Ivo Kwee;Davide Rossi

  • Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk

    Dalemari Crowther-Swanepoel;Peter Broderick;Maria Chiara Di Bernardo;Sara E. Dobbins

  • Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status.

    Mia Thorsélius;Alexander Kröber;Fiona Murray;Ulf Thunberg

  • Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration.

    Terese T. Horlocker;Allen W. Burton;Richard T. Connis;Samuel C. Hughes

Frequent Co-Authors

Kostas Stamatopoulos
Kostas Stamatopoulos Centre for Research and Technology Hellas
Paolo Ghia
Paolo Ghia Vita-Salute San Raffaele University
Šárka Pospíšilová
Šárka Pospíšilová Masaryk University
David Oscier
David Oscier Royal Bournemouth Hospital
Frederic Davi
Frederic Davi Assistance Publique – Hôpitaux de Paris
Gunnar Juliusson
Gunnar Juliusson Lund University
Karin E. Smedby
Karin E. Smedby Karolinska University Hospital
Christer Sundström
Christer Sundström Uppsala University
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Nicholas Chiorazzi
Nicholas Chiorazzi Feinstein Institute for Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Richard Rosenquist

Trending Scientists

Recently Published Articles